PharmaCyte Biotech

$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-26-000147  Size: 7 KB 网页链接

$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-26-000148  Size: 15 KB 网页链接

$PharmaCyte Biotech(PMCB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-25-009259  Act: 34  Size: 6 MB 网页链接

$PharmaCyte Biotech(PMCB)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001683168-25-009154  Act: 34  Size: 20 KB 网页链接

$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-25-009112  Size: 9 KB 网页链接

$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-25-009113  Size: 16 KB 网页链接

$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-25-009115  Size: 8 KB 网页链接

$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-25-009114  Size: 7 KB 网页链接

$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-25-009116  Size: 8 KB 网页链接

$PharmaCyte Biotech(PMCB)$ 8-K Current report, item 3.01 Accession Number: 0001683168-25-008947  Act: 34  Size: 194 KB 网页链接

$PharmaCyte Biotech(PMCB)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001683168-25-008515  Size: 17 KB 网页链接

$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-25-008517  Act: 34  Size: 8 KB 网页链接

$PharmaCyte Biotech(PMCB)$ 8-K/A [Amend] Current report, item 9.01 Accession Number: 0001683168-25-008512  Act: 34  Size: 2 MB 网页链接

$PharmaCyte Biotech(PMCB)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001213900-25-107726  Act: 34  Size: 18 KB 网页链接

$PharmaCyte Biotech(PMCB)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001683168-25-007871  Act: 34  Size: 350 KB 网页链接

$PharmaCyte Biotech(PMCB)$ DEF 14A Other definitive proxy statements Accession Number: 0001683168-25-007435  Act: 34  Size: 1 MB 网页链接

$PharmaCyte Biotech(PMCB)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003122  Act: 33  Size: 1 KB 网页链接

$PharmaCyte Biotech(PMCB)$ PRE 14A Other preliminary proxy statements Accession Number: 0001683168-25-007217  Act: 34  Size: 312 KB 网页链接

$PharmaCyte Biotech(PMCB)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001683168-25-007041  Act: 33  Size: 23 MB 网页链接

$PharmaCyte Biotech(PMCB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-25-006991  Act: 34  Size: 4 MB 网页链接